Know our story
LSE BioTech International is the culmination of many year’s research and development. We employ the sharpest minds, the most innovative technologies, and a genuine passion for enriching people’s lives; This is what separates LSE from the pack, and allows us to truly promote the field of photomedicine.
LSE BioTech was formed in an effort to eliminate the need for medications and surgical procedures wherever possible. Based in the United States, our team of experts utilizes the process of photobiomodulation to treat a variety of ailments and chronic pains both nationally and abroad. We believe in our team, and we know a thing or two about science. The human species is like no other on the planet. We are capable of understanding our own biology, and more importantly, changing it when necessary. Utilizing the most advanced photobiomodulation systems the world has ever seen, LSE is capable of delivering on our mission.
Our Mission is simple: To deliver the most cutting edge approach to health and optimal performance with the least amount of negative side effects as possible. Using the cutting edge sciences of photomedicine, we are able to do just that.
This noninvasive, natural, and highly impactful area of science gives us the ability to do things never before seen in healthcare. Our goal is to further the understanding of photosciences and promote the general health and well-being of people around the world. Whether it is helping reverse the effects of Parkinson’s disease, or optimizing the professional athlete’s ability to utilize oxygen efficiently, LSE BioTech is advancing the Healthcare Industry while building lifelong relationships with our clients. This is our mission, and this is LSE BioTech.
Lighting the Path Forward
LSE BioTech has expanded our model internationally. We have partnered with some of the world's leading research teams to be able to offer our science and services to individuals around the globe! In addition, LSE continues to be passionate about helping children and finding alternative treatments for childhood diseases. That is why we donate 10% of our earnings to childhood disease research. As we continue our initiatives, we are working to help many areas of science through our efforts.
- Cardiovascular Diseases
- Alzheimer’s and Dementia
- Parkinson’s Disease
- Athletic Optimization